.svg){kind=small}
%25202024%2520img.png)
Richmond Pharmacology is proud to announce its participation in TheLiver Meeting 2024, hosted by the American Association for the Study of LiverDiseases (AASLD). This event gathers leading hepatology experts to discussgroundbreaking research and advancements in liver diseases. The conference willfeature a wide range of sessions, including state-of-the-art lectures,workshops, and networking opportunities.
To connect with our team during the event, please reach out to arrange ameeting.
For more information, visit the AASLD Liver Meeting 2024 website.
-min.jpg)
.jpg)
Latest news
Richmond Appoints Lisa Campbell as Director of Regulatory Strategy
April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read moreVon Willebrand Disease – First Stage of Hemab Therapeutics’ Trial Completed and New Patients Invited to Enrol
April 2, 2025
Richmond has completed dosing the first cohort of patients in Velora Pioneer, a phase 1/2 clinical trial investigating Hemab...
Read moreEvents
Swiss Biotech Day 2025
5–6 May 2025
Richmond Pharmacology is pleased to confirm our participation at Swiss Biotech Day 2025
View event
